title: Potential use of RNA interference as therapeutic strategy in urologic cancer.
authors: Royal Derby Hospital, Derby, United Kingdom. William.Green@nhs.net
authors: William J F
authors: WJ
authors: Green
authors: Phillip A
authors: PA
authors: James
authors: Hari L
authors: HL
authors: Ratan
mesh_terms: D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000628:therapy; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D020868:Gene Silencing; D019254:Genes, bcl-2 / Q000235:genetics; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000235:genetics; D007680:Kidney Neoplasms / Q000235:genetics / Q000628:therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics / Q000628:therapy; D034622:RNA Interference / Q000502:physiology*; D034741:RNA, Small Interfering / Q000627:therapeutic use*; D000077022:Survivin; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000628:therapy; D014565:Urogenital Neoplasms / Q000235:genetics / Q000628:therapy*
chemical_list: D051017:Apoptosis Regulatory Proteins; C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D034741:RNA, Small Interfering; D000077022:Survivin